Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is technically challenging but increasingly performed in specialist centres. The aim of this study was to compare outcomes of exenteration over time. Methods This was a multicentre retrospective study of patients who underwent exenteration for LARC and LRRC between 2004 and 2015. Surgical outcomes, including rate of bone resection, flap reconstruction, margin status and transfusion rates, were examined. Outcomes between higher- and lower-volume centres were also evaluated. Results Some 2472 patients underwent pelvic exenteration for LARC and LRRC across 26 institutions. For LARC, rates of bone resection or flap reconstruction ...
Objective: To assess the outcomes and patterns of treatment failure of patients who underwent pelvic...
Background: Most published data on pelvic exenteration comes from high-volume quaternary units, with...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Background Pelvic exenteration is the only radical treatment for locally advanced (ARC) or recurrent...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
AIM To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced ...
To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced prim...
BACKGROUND: Over one-third of primary rectal cancers are locally advanced at diagnosis, and local re...
Background: Since its first description in 1948, total pelvic exenteration has been a surgical optio...
The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been clearly define...
Aims: To report the role of total pelvic exenteration in a series of locally advanced and recurrent ...
Background: The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been cl...
Background. Patients with stage T4 rectal cancer are known to have poor survival and often require p...
Objective: To assess the outcomes and patterns of treatment failure of patients who underwent pelvic...
Background: Most published data on pelvic exenteration comes from high-volume quaternary units, with...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Background Pelvic exenteration is the only radical treatment for locally advanced (ARC) or recurrent...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
AIM To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced ...
To identify short-term and oncologic outcomes of pelvic exenterations (PE) for locally advanced prim...
BACKGROUND: Over one-third of primary rectal cancers are locally advanced at diagnosis, and local re...
Background: Since its first description in 1948, total pelvic exenteration has been a surgical optio...
The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been clearly define...
Aims: To report the role of total pelvic exenteration in a series of locally advanced and recurrent ...
Background: The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been cl...
Background. Patients with stage T4 rectal cancer are known to have poor survival and often require p...
Objective: To assess the outcomes and patterns of treatment failure of patients who underwent pelvic...
Background: Most published data on pelvic exenteration comes from high-volume quaternary units, with...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...